SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,000 | -37.5% | 19,416 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | +14.3% | 19,416 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | -50.0% | 19,416 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | 0.0% | 19,416 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | -41.7% | 19,416 | 0.0% | 0.00% | – |
| Q1 2019 | $24,000 | +200.0% | 19,416 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -79.5% | 19,416 | 0.0% | 0.00% | – |
| Q3 2018 | $39,000 | -4.9% | 19,416 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | -22.6% | 19,416 | 0.0% | 0.00% | – |
| Q1 2018 | $53,000 | -26.4% | 19,416 | 0.0% | 0.00% | – |
| Q4 2017 | $72,000 | +89.5% | 19,416 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -26.9% | 19,416 | 0.0% | 0.00% | – |
| Q2 2017 | $52,000 | -35.0% | 19,416 | 0.0% | 0.00% | – |
| Q1 2017 | $80,000 | +14.3% | 19,416 | 0.0% | 0.00% | – |
| Q4 2016 | $70,000 | -17.6% | 19,416 | 0.0% | 0.00% | – |
| Q3 2016 | $85,000 | – | 19,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|